Insider Transactions in Q4 2021 at Insmed Inc (INSM)
Insider Transaction List (Q4 2021)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 27
2021
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
46,614
-18.73%
|
$1,258,578
$27.72 P/Share
|
Dec 27
2021
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
46,614
+15.78%
|
$652,596
$14.24 P/Share
|
Dec 23
2021
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
50,000
-10.19%
|
$1,400,000
$28.21 P/Share
|
Dec 23
2021
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+8.7%
|
$400,000
$8.82 P/Share
|
Nov 19
2021
|
Melvin Md Sharoky Director |
SELL
Bona fide gift
|
Direct |
1,900
-0.8%
|
-
|
Nov 01
2021
|
Steinar J Engelsen |
BUY
Open market or private purchase
|
Direct |
14,235
+4.25%
|
$427,050
$30.14 P/Share
|
Nov 01
2021
|
David R Brennan Director |
BUY
Open market or private purchase
|
Direct |
10,000
+11.0%
|
$300,000
$30.15 P/Share
|
Nov 01
2021
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
61,000
-27.28%
|
$1,830,000
$30.68 P/Share
|
Nov 01
2021
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
61,000
+35.16%
|
$732,000
$12.44 P/Share
|